Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases
- PMID: 690689
- DOI: 10.3171/jns.1978.49.4.0597
Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases
Abstract
The association of myopathy with epsilon-aminocaproic acid (EACA) treatment after subarachnoid hemorrhage in two cases is reported. Clinical and laboratory findings and possible mechanisms are discussed in light of the known pharmacology of the drug. Recovery ensues if EACA treatment is terminated as soon as myopathy appears.
Similar articles
-
Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review.Ital J Neurol Sci. 1983 Dec;4(4):489-92. doi: 10.1007/BF02125632. Ital J Neurol Sci. 1983. PMID: 6674249
-
Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report.J Neurosurg. 1980 Nov;53(5):690-2. doi: 10.3171/jns.1980.53.5.0690. J Neurosurg. 1980. PMID: 7431078
-
Epsilon-aminocaproic acid myopathy. Report of a case and literature review.Eur Neurol. 1982;21(4):242-8. doi: 10.1159/000115487. Eur Neurol. 1982. PMID: 7117311
-
Myonecrosis as a complication of the use of epsilon amino-caproic acid: a case report and review of the literature.Am J Med. 1988 Dec;85(6):861-3. doi: 10.1016/s0002-9343(88)80037-8. Am J Med. 1988. PMID: 3057905 Review. No abstract available.
-
The complications of therapy with epsilon-aminocaproic acid.Med Clin North Am. 1966 Nov;50(6):1669-78. doi: 10.1016/s0025-7125(16)33112-1. Med Clin North Am. 1966. PMID: 5339196 Review. No abstract available.
Cited by
-
Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review.Ital J Neurol Sci. 1983 Dec;4(4):489-92. doi: 10.1007/BF02125632. Ital J Neurol Sci. 1983. PMID: 6674249
-
Inhibitors of fibrinolysis in the treatment of haemophilia.J Clin Pathol Suppl (R Coll Pathol). 1980;14:50-4. J Clin Pathol Suppl (R Coll Pathol). 1980. PMID: 7000847 Free PMC article. Review. No abstract available.
-
Antifibrinolytic agents in subarachnoid haemorrhage.J Neurol. 1987 Jan;234(1):1-8. doi: 10.1007/BF00314000. J Neurol. 1987. PMID: 3546604 Review.
-
Adverse effects of drugs on muscle.Drugs. 1982 Oct;24(4):304-21. doi: 10.2165/00003495-198224040-00003. Drugs. 1982. PMID: 6128217 Review.
-
Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.Neurocrit Care. 2008;8(3):418-26. doi: 10.1007/s12028-008-9088-5. Neurocrit Care. 2008. PMID: 18386187 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources